PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Phillips DiPisa

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Basilea Pharmaceuticals, Inc. Appoints National Sales Director - Phillips DiPisa completes a search assignment for Basilea Pharmaceuticals, Inc. Company appoints Ken Farah as National Sales Director for its Ceftobiprole drug
Basilea Pharmaceuticals, Inc. Appoints National Sales Director

 

NewswireToday - /newswire/ - Hingham, MA, United States, 2007/10/09 - Phillips DiPisa completes a search assignment for Basilea Pharmaceuticals, Inc. Company appoints Ken Farah as National Sales Director for its Ceftobiprole drug.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Phillips DiPisa, a retained executive search firm serving healthcare providers, managed care organizations, and life sciences firms, today announced that it has completed an executive search assignment for Basilea Pharmaceuticals, Inc.

Basilea Pharmaceuticals, Inc., a newly launched U.S. subsidiary of Switzerland's Basilea Pharmaceutica, hired Ken Farah as the National Sales Director. Phillips DiPisa led the search on behalf of Basilea Pharmaceuticals.

At Basilea, Farah will lead the company’s first sales team for Ceftobiprole, which is awaiting FDA approval to treat methicillin-resistant staff infections.

Farah has over 25 years of sales and sales management experience launching specialty anti-infective and oncology products in the hospital markets. Most recently, Farah was a Sales Director for Dendreon Corporation. Prior, he managed regions around the country for Ortho McNeil/Alza, where he helped build the specialty sales force for the ADHD drug Concerta.

Farah also served at ALZA, Sequus and Immunex, in capacities such as Regional Manager, Director of Strategic Oncology accounts and Oncology Account Executive. He began his career in sales at Lederle, where he rose to management in the hospital division and concentrated on antibiotic sales in the hospital marketplace.

Basilea Pharmaceutica Ltd. is a biopharmaceutical company focused on new antibacterial and antifungal agents to fight drug resistance and on the development of dermatology drugs. Basilea’s products are targeted to satisfy high medical and patient needs in the hospital and specialty care setting. The company owns a diversified portfolio, including three investigational phase III drugs of which two have shown positive pivotal phase III results.

Kevin Carroll was Phillips DiPisa’s associate responsible for this engagement.

About Phillips DiPisa

Phillips DiPisa (phillipsdipisa.com) recruits leaders for healthcare providers, managed care organizations, and life sciences firms. The firm’s roots are in Greater Boston – a historical center of medical innovation and excellence. Phillips DiPisa now serves clients along the East Coast and throughout the Midwest, and draws on a national pool of candidates.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Phillips DiPisa

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Basilea Pharmaceuticals, Inc. Appoints National Sales Director

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Beth Mills - PhillipsDiPisa.com 
781-740-9699 bamills[.]phillipsdipisa.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Phillips DiPisa securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Phillips DiPisa / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

FDA Grants Breakthrough Therapy Designation for Rituxan® (Rituximab) in Pemphigus Vulgaris
MDxHealth Signs Agreement with Lab21 to Make SelectMDx Liquid Biopsy Test Available in the United Kingdom
Greenphire Drives Global Site Adoption of Clinical Trial Payment Solutions
SelectMDx Chosen by Michigan Medicine as Pre-biopsy Diagnostic Tool in Groundbreaking US Prostate Cancer Risk Clinic
BTG Announces CE Mark Certification for DC Bead LUMI™ - The First Commercially Available Radiopaque Drug-Eluting Bead
Sartorius to Acquire Real-time Live-cell Analysis Pioneer and Leader Essen BioScience
Pyxis™ ES System to Help U.S. Department of Defense Advance Medication Safety and Patient Care
BTG Receives U.S. FDA 510(k) Clearance for EKOS® Control Unit 4.0
MDxHealth Announces Agreement with Istituto Diagnostico Varelli for Distribution of SelectMDx Throughout Central-South Italy
BD Veritor™ System Meets FDA’s New Performance Requirements for Rapid Influenza Antigen Detection Tests
Sub-Sahara Africa - Increase in Western Lifestyles Leads to Dire Need for Chronic Prescription Drugs Finds Frost & Sullivan
BD Initiates New Industry Alliance to Combat Rising Opioid Crisis
BTG and Society of Interventional Oncology to Explore Role of Minimally Invasive Therapies in Immuno-oncology
Ipsen to Acquire a Portfolio of Select Consumer Healthcare Products from Sanofi
BD Announces Early Access Program for BD Resolve™ Single-Cell Analysis Platform

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  MagLar, Inc.

Visit  JobsWare.com





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)